Implantable polymeric device for sustained release of buprenorphine

Details for Australian Patent Application No. 2008212011 (hide)

International Classifications

Event Publications

25 September 2008 Application Open to Public Inspection

Published as AU-B-2008212011

25 September 2008 Complete Application Filed

7 January 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

11 March 2010 Section 223 Application Received

Titan Pharmaceuticals, Inc. An application to extend the time from 02 Jun 2009 to 02 Jan 2010 in which to pay a continuation fee has been filed . Address for service in Australia - FB Rice & Co Level 23 44 Market Street Sydney NSW 2000

6 May 2010 Section 223 Application Allowed

Titan Pharmaceuticals, Inc. The time in which to pay a continuation fee has been extended to 02 Jan 2010. Address for service in Australia - FB Rice & Co Level 23 44 Market Street Sydney NSW 2000

27 May 2010 Application Accepted

Published as AU-B-2008212011

23 September 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.